1
2
2
End Prescription Drug Ads Now Act
7/31/2025, 4:23 AM
Summary of Bill HR 4605
The bill titled "To ban drug manufacturers from using direct-to-consumer advertising, including social media, to promote their products" was introduced in the 119th Congress as H.R. 4605 on July 22, 2025.
Read the Full Bill
Current Status of Bill HR 4605
Bill HR 4605 is currently in the status of Bill Introduced since July 22, 2025. Bill HR 4605 was introduced during Congress 119 and was introduced to the House on July 22, 2025. Bill HR 4605's most recent activity was Referred to the House Committee on Energy and Commerce. as of July 22, 2025
Bipartisan Support of Bill HR 4605
Total Number of Sponsors
3Democrat Sponsors
3Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
2Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 4605
Primary Policy Focus
Alternate Title(s) of Bill HR 4605
End Prescription Drug Ads Now Act
End Prescription Drug Ads Now Act
To ban drug manufacturers from using direct-to-consumer advertising, including social media, to promote their products.
Comments
Sponsors and Cosponsors of HR 4605
Latest Bills
Making Reviews Certain Act
Bill HR 8249April 20, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2022-07: Reasonable Investigation of Consumer Reporting Disputes".
Bill SJRES 173April 20, 2026
Expressing support for the designation of the month of April 2026 as "Parkinson's Awareness Month".
Bill HRES 1167April 20, 2026
Recognizing U.S. Immigration and Customs Enforcement for their work in protecting communities from violent criminals and illegal aliens.
Bill HRES 1168April 20, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2022-02: Deceptive Representations Involving the FDIC's Name or Logo or Deposit Insurance".
Bill SJRES 175April 20, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to "Registry of Nonbank Covered Persons Subject to Certain Agency and Court Orders; Rescission".
Bill SJRES 177April 20, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Disclosure of Consumer Complaint Narrative Data".
Bill SJRES 176April 20, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Information Requests to Large Banks and Credit Unions".
Bill SJRES 167April 20, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2022-04: Insufficient Data Protection or Security for Sensitive Consumer Information".
Bill SJRES 164April 20, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Bulletin 2015-02 re: Section 8 housing choice voucher homeownership program".
Bill SJRES 165April 20, 2026